CirChem (CIRCHE) Status Update summary
Event summary combining transcript, slides, and related documents.
Status Update summary
12 Oct, 2026Information memorandum and use of proceeds
Information memorandum published for the upcoming board-approved rights issue; full terms and instructions are available on the issuer’s and Eminova’s websites.
Gross proceeds of ~SEK 13.4m are intended for capacity expansion, completion of a quality-assurance laboratory, commercialization of automotive and paint-industry customer collaborations, and preparation of future storage and production areas.
Offer terms
Record date: 9 June 2025; eligible shareholders receive 1 subscription right per share, and 5 rights entitle holders to subscribe for 1 new share at SEK 2.0.
Subscription period runs from 11 to 25 June 2025.
Commitments and timetable
~68.2% of the issue is covered by subscription commitments and guarantees; commitments from board and management members total ~SEK 1.2m, or ~9.1%, including CEO Petra Sas and chair Mats Persson via entities.
Bottom guarantees total ~SEK 6.8m, or ~50.9%, from external investors; Almi Invest Fond SI AB provided a compensation-free top-down guarantee of ~SEK 1.1m, or ~8.2%.
Subscription-right trading runs 11–19 June; BTA trading begins 11 June; preliminary issue outcome is expected 27 June 2025.
Latest events from CirChem
- Revenue fell and losses widened, but new contracts and financing support future growth.CIRCHE
Q2 2026 - Recurring business stabilizes as one-off effects fade; new contracts drive future growth.CIRCHE
Q1 2026 - Recurring business normalized in 2025, with focus shifting to profitability and strategic growth.CIRCHE
Q4 2025 - Sales and earnings fell sharply in Q3, but new financing and contracts support future growth.CIRCHE
Q3 2025 - Record sales growth and improved margins, supported by new financing and strong industry demand.CIRCHE
Q2 2025 - Record Q3 profit and sales mark a turning point as CirChem accelerates sustainable growth.CIRCHE
Q3 2024 - Revenue up 164% in H1 2024, losses reduced, and major contracts drive expansion.CIRCHE
Q2 2024 - Q1 net sales up 82% and EBIT loss cut by 62%, with strong progress in key industrial segments.CIRCHE
Q1 2025 - Record revenue growth and break-even achieved as CirChem expands circular recycling.CIRCHE
Q4 2024